Global Anti-obesity Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

December 2023 | 109 pages | ID: G2138004DB11EN
Maia Research

Abstracts

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Anti-obesity Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Anti-obesity Drugs market are covered in Chapter 9:
Currax Pharmaceuticals LLC
VIVUs Inc.
Novo Nordisk A/S
Teva Pharmaceutical Industries Ltd.
F.Hoffmann-La Roche Ltd
Sandoz lnternational GmbH (Novartis AG)
GlaxoSmithKline plc
In Chapter 5 and Chapter 7.3, based on types, the Anti-obesity Drugs market from 2017 to 2027 is primarily split into:
Prescription
Over-the-Counter (OTC)
In Chapter 6 and Chapter 7.4, based on applications, the Anti-obesity Drugs market from 2017 to 2027 covers:
Appetite Suppression
Fat Blocking
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Anti-obesity Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Anti-obesity Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027

Contents

1 ANTI-OBESITY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Anti-obesity Drugs Market
1.2 Anti-obesity Drugs Market Segment by Type
  1.2.1 Global Anti-obesity Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Anti-obesity Drugs Market Segment by Application
  1.3.1 Anti-obesity Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Anti-obesity Drugs Market, Region Wise (2017-2027)
  1.4.1 Global Anti-obesity Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.3 Europe Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.4 China Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.5 Japan Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.6 India Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.8 Latin America Anti-obesity Drugs Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Anti-obesity Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Anti-obesity Drugs (2017-2027)
  1.5.1 Global Anti-obesity Drugs Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Anti-obesity Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Anti-obesity Drugs Market

2 INDUSTRY OUTLOOK

2.1 Anti-obesity Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Anti-obesity Drugs Market Drivers Analysis
2.4 Anti-obesity Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Anti-obesity Drugs Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Anti-obesity Drugs Industry Development

3 GLOBAL ANTI-OBESITY DRUGS MARKET LANDSCAPE BY PLAYER

3.1 Global Anti-obesity Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Anti-obesity Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Anti-obesity Drugs Average Price by Player (2017-2022)
3.4 Global Anti-obesity Drugs Gross Margin by Player (2017-2022)
3.5 Anti-obesity Drugs Market Competitive Situation and Trends
  3.5.1 Anti-obesity Drugs Market Concentration Rate
  3.5.2 Anti-obesity Drugs Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL ANTI-OBESITY DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Anti-obesity Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Anti-obesity Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Anti-obesity Drugs Market Under COVID-19
4.5 Europe Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Anti-obesity Drugs Market Under COVID-19
4.6 China Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Anti-obesity Drugs Market Under COVID-19
4.7 Japan Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Anti-obesity Drugs Market Under COVID-19
4.8 India Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Anti-obesity Drugs Market Under COVID-19
4.9 Southeast Asia Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Anti-obesity Drugs Market Under COVID-19
4.10 Latin America Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Anti-obesity Drugs Market Under COVID-19
4.11 Middle East and Africa Anti-obesity Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Anti-obesity Drugs Market Under COVID-19

5 GLOBAL ANTI-OBESITY DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Anti-obesity Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Anti-obesity Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Anti-obesity Drugs Price by Type (2017-2022)
5.4 Global Anti-obesity Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Anti-obesity Drugs Sales Volume, Revenue and Growth Rate of Prescription (2017-2022)
  5.4.2 Global Anti-obesity Drugs Sales Volume, Revenue and Growth Rate of Over-the-Counter (OTC) (2017-2022)

6 GLOBAL ANTI-OBESITY DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Anti-obesity Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Anti-obesity Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Anti-obesity Drugs Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Anti-obesity Drugs Consumption and Growth Rate of Appetite Suppression (2017-2022)
  6.3.2 Global Anti-obesity Drugs Consumption and Growth Rate of Fat Blocking (2017-2022)
  6.3.3 Global Anti-obesity Drugs Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL ANTI-OBESITY DRUGS MARKET FORECAST (2022-2027)

7.1 Global Anti-obesity Drugs Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Anti-obesity Drugs Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Anti-obesity Drugs Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Anti-obesity Drugs Price and Trend Forecast (2022-2027)
7.2 Global Anti-obesity Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Anti-obesity Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Anti-obesity Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Anti-obesity Drugs Revenue and Growth Rate of Prescription (2022-2027)
  7.3.2 Global Anti-obesity Drugs Revenue and Growth Rate of Over-the-Counter (OTC) (2022-2027)
7.4 Global Anti-obesity Drugs Consumption Forecast by Application (2022-2027)
  7.4.1 Global Anti-obesity Drugs Consumption Value and Growth Rate of Appetite Suppression(2022-2027)
  7.4.2 Global Anti-obesity Drugs Consumption Value and Growth Rate of Fat Blocking(2022-2027)
  7.4.3 Global Anti-obesity Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Anti-obesity Drugs Market Forecast Under COVID-19

8 ANTI-OBESITY DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Anti-obesity Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Anti-obesity Drugs Analysis
8.6 Major Downstream Buyers of Anti-obesity Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Anti-obesity Drugs Industry

9 PLAYERS PROFILES

9.1 Currax Pharmaceuticals LLC
  9.1.1 Currax Pharmaceuticals LLC Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.1.3 Currax Pharmaceuticals LLC Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 VIVUs Inc.
  9.2.1 VIVUs Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.2.3 VIVUs Inc. Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Novo Nordisk A/S
  9.3.1 Novo Nordisk A/S Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.3.3 Novo Nordisk A/S Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Teva Pharmaceutical Industries Ltd.
  9.4.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.4.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 F.Hoffmann-La Roche Ltd
  9.5.1 F.Hoffmann-La Roche Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.5.3 F.Hoffmann-La Roche Ltd Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Sandoz lnternational GmbH (Novartis AG)
  9.6.1 Sandoz lnternational GmbH (Novartis AG) Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.6.3 Sandoz lnternational GmbH (Novartis AG) Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 GlaxoSmithKline plc
  9.7.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Anti-obesity Drugs Product Profiles, Application and Specification
  9.7.3 GlaxoSmithKline plc Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES




Figure Anti-obesity Drugs Product Picture

Table Global Anti-obesity Drugs Market Sales Volume and CAGR (%) Comparison by Type

Table Anti-obesity Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Anti-obesity Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Anti-obesity Drugs Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Anti-obesity Drugs Industry Development

Table Global Anti-obesity Drugs Sales Volume by Player (2017-2022)

Table Global Anti-obesity Drugs Sales Volume Share by Player (2017-2022)

Figure Global Anti-obesity Drugs Sales Volume Share by Player in 2021

Table Anti-obesity Drugs Revenue (Million USD) by Player (2017-2022)

Table Anti-obesity Drugs Revenue Market Share by Player (2017-2022)

Table Anti-obesity Drugs Price by Player (2017-2022)

Table Anti-obesity Drugs Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Anti-obesity Drugs Sales Volume, Region Wise (2017-2022)

Table Global Anti-obesity Drugs Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Anti-obesity Drugs Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Anti-obesity Drugs Sales Volume Market Share, Region Wise in 2021

Table Global Anti-obesity Drugs Revenue (Million USD), Region Wise (2017-2022)

Table Global Anti-obesity Drugs Revenue Market Share, Region Wise (2017-2022)

Figure Global Anti-obesity Drugs Revenue Market Share, Region Wise (2017-2022)

Figure Global Anti-obesity Drugs Revenue Market Share, Region Wise in 2021

Table Global Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Anti-obesity Drugs Sales Volume by Type (2017-2022)

Table Global Anti-obesity Drugs Sales Volume Market Share by Type (2017-2022)

Figure Global Anti-obesity Drugs Sales Volume Market Share by Type in 2021

Table Global Anti-obesity Drugs Revenue (Million USD) by Type (2017-2022)

Table Global Anti-obesity Drugs Revenue Market Share by Type (2017-2022)

Figure Global Anti-obesity Drugs Revenue Market Share by Type in 2021

Table Anti-obesity Drugs Price by Type (2017-2022)

Figure Global Anti-obesity Drugs Sales Volume and Growth Rate of Prescription (2017-2022)
Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate of Prescription (2017-2022)
Figure Global Anti-obesity Drugs Sales Volume and Growth Rate of Over-the-Counter (OTC) (2017-2022)
Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate of Over-the-Counter (OTC) (2017-2022)
Table Global Anti-obesity Drugs Consumption by Application (2017-2022)

Table Global Anti-obesity Drugs Consumption Market Share by Application (2017-2022)

Table Global Anti-obesity Drugs Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Anti-obesity Drugs Consumption Revenue Market Share by Application (2017-2022)

Table Global Anti-obesity Drugs Consumption and Growth Rate of Appetite Suppression (2017-2022)
Table Global Anti-obesity Drugs Consumption and Growth Rate of Fat Blocking (2017-2022)
Table Global Anti-obesity Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Anti-obesity Drugs Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Anti-obesity Drugs Price and Trend Forecast (2022-2027)

Figure USA Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Anti-obesity Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Anti-obesity Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Anti-obesity Drugs Market Sales Volume Forecast, by Type

Table Global Anti-obesity Drugs Sales Volume Market Share Forecast, by Type

Table Global Anti-obesity Drugs Market Revenue (Million USD) Forecast, by Type

Table Global Anti-obesity Drugs Revenue Market Share Forecast, by Type

Table Global Anti-obesity Drugs Price Forecast, by Type

Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate of Prescription (2022-2027)
Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate of Prescription (2022-2027)
Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate of Over-the-Counter (OTC) (2022-2027)
Figure Global Anti-obesity Drugs Revenue (Million USD) and Growth Rate of Over-the-Counter (OTC) (2022-2027)
Table Global Anti-obesity Drugs Market Consumption Forecast, by Application

Table Global Anti-obesity Drugs Consumption Market Share Forecast, by Application

Table Global Anti-obesity Drugs Market Revenue (Million USD) Forecast, by Application

Table Global Anti-obesity Drugs Revenue Market Share Forecast, by Application

Figure Global Anti-obesity Drugs Consumption Value (Million USD) and Growth Rate of Appetite Suppression (2022-2027)
Figure Global Anti-obesity Drugs Consumption Value (Million USD) and Growth Rate of Fat Blocking (2022-2027)
Figure Global Anti-obesity Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Anti-obesity Drugs Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Currax Pharmaceuticals LLC Profile
Table Currax Pharmaceuticals LLC Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Currax Pharmaceuticals LLC Anti-obesity Drugs Sales Volume and Growth Rate
Figure Currax Pharmaceuticals LLC Revenue (Million USD) Market Share 2017-2022
Table VIVUs Inc. Profile
Table VIVUs Inc. Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure VIVUs Inc. Anti-obesity Drugs Sales Volume and Growth Rate
Figure VIVUs Inc. Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk A/S Profile
Table Novo Nordisk A/S Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk A/S Anti-obesity Drugs Sales Volume and Growth Rate
Figure Novo Nordisk A/S Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Anti-obesity Drugs Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table F.Hoffmann-La Roche Ltd Profile
Table F.Hoffmann-La Roche Ltd Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F.Hoffmann-La Roche Ltd Anti-obesity Drugs Sales Volume and Growth Rate
Figure F.Hoffmann-La Roche Ltd Revenue (Million USD) Market Share 2017-2022
Table Sandoz lnternational GmbH (Novartis AG) Profile
Table Sandoz lnternational GmbH (Novartis AG) Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz lnternational GmbH (Novartis AG) Anti-obesity Drugs Sales Volume and Growth Rate
Figure Sandoz lnternational GmbH (Novartis AG) Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Anti-obesity Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Anti-obesity Drugs Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022